Document is current
Any future updates will be listed below
-
Authors
Mookherjee, Neeloffer http://orcid.org/0000-0002-9350-4157
Anderson, Marilyn A. http://orcid.org/0000-0002-8257-5128
Haagsman, Henk P. http://orcid.org/0000-0002-4931-5201
Davidson, Donald J. http://orcid.org/0000-0002-8782-199X
- License Information
-
More Information
Article History
Accepted: 18 December 2019
First Online: 27 February 2020
Competing interests
: N.M. is listed as an inventor on patents related to immunomodulatory aspects of host defence peptides and IDR peptides. M.A.A. is Chief Scientific Officer and Director of the start-up company Hexima, which has a cationic antimicrobial peptide in clinical trials for treatment of onychomycosis. H.P.H. owns stock in the start-up company Celestial Therapeutics Inc. and has patents on antimicrobial peptide therapeutics licensed to Zoetis. D.J.D. declares no conflict of interest.
